Diagnostic and therapeutic implications of endoscopic resection in EUS-staged T2 esophageal adenocarcinoma
Recruiting
- Conditions
- Esophageal Adenocarcinoma (EAC), Esophagectomy, Slokdarmkanker, Endoscopic Ultrasound
- Registration Number
- NL-OMON26531
- Lead Sponsor
- Erasmus Medical Center Rotterdam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Patients aged > 18 years, with a biopsy proven esophageal adenocarcinoma, staged as a cT2N0M0 lesion.
Exclusion Criteria
- Presence of metastasize disease
- Presence of (cytology proven) lymph node metastasis
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To prospectively evaluate the value of an endoscopic reassessment of patients with an initial diagnosis of a cT2 EAC by an experienced therapeutic endoscopist, followed by ER of the lesion if deemed possible. Expressed as the number of lesions that are downstaged to a T1 lesion after reassessment and endoscopic resection.
- Secondary Outcome Measures
Name Time Method To prospectively evaluate the number of lesions that are within currently accepted criteria for endoscopic resection